Healthcare-associated C. difficile infections: acquisition of C

Slides:



Advertisements
Similar presentations
This slide set “Hand Hygiene in Healthcare Settings- Core” and accompanying speaker notes provide an overview of the Guideline for Hand Hygiene in Health-
Advertisements

Development of Healthcare- Associated Infections: Role of the Built Environment James P. Steinberg, MD Division of Infectious Diseases Emory University.
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
Innovative Use of Electronic Hand Hygiene Monitoring to Control a Clostridium difficile cluster on a Hematopoietic Stem Cell Transplant Unit Natasha Robinson.
IMPROVING HAND HYGIENE PRACTICES IN HEALTHCARE SETTINGS IMPROVING HAND HYGIENE PRACTICES IN HEALTHCARE SETTINGS.
Cleaning in the ICU: strong evidence, strong convictions and a dose of reality? Cleaning in the ICU: strong evidence, strong convictions and a dose of.
Infection Prevention & Control Annual Report 2007/08 (2008/09 update) Dr Patricia O’Neill Director of Infection Prevention & Control 25 th September 2008.
A Tiered Approach to Reduce Hospital Onset C. difficile Brian Koll, MD, FACP, FIDSA Medical Director and Chief Infection Prevention and Control, BIMC.
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Hand Hygiene Unfashionable & Undervalued but Important Hilary Humphreys Royal College of Surgeons in Ireland (RCSI) & Beaumont Hospital, Dublin.
Effective Surface Decontamination Product and Practice = Perfection.
William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety; Research Professor of Medicine and Director, Statewide Program.
To screen or not to screen – Clostridium difficile Simon Goldenberg, Consultant Microbiologist Guy’s & St Thomas’ NHS Foundation Trust.
Course Code: NUR 240 Lecture ( 3). 1.The Risk of Infection is always Present in every Hospital. 2.Identify frequency of nosocomial infection.
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
Jane Stockley Chris Catchpole Carole Clive November 2012.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
My favourite papers on…environmental decontamination Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
David Tucker Honorary Treasurer Infection Prevention Society.
The healthcare environment: automated disinfection provides more effective infection prevention than manual disinfection Jon Otter, PhD FRCPath Imperial.
cleanyourhands campaign
Impact Of Intensity Of Glucose Control On Lactate Levels In Children After Cardiac Surgery Fule BK1, Kanthimathinathan HK3 Gan CS1, Davies P2, Laker S1,
The emerging challenge of contaminated water heater-coolers used for cardiothoracic surgery and the risk of Mycobacterium chimaera infections Jon Otter,
Disinfection of rooms and surfaces - what are the global trends and latest scientific discoveries when it comes to technology and materials? Jon Otter,
Eradicating Clostridium Difficile in Hospital Settings
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
Your hospital room can make you sick
C. difficile Detection and the Importance of Proper Specimen Collection and Testing [Name] [Title]
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
Improvement of management and reduction in mortality following implementation of audit recommendations in Clostridium difficile diarrhoea at James Cook.
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
IPC – new, novel, and exciting
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Introduction to epidemiology (and infection)
Practical Approaches for Monitoring Cleaning in Healthcare Facilities
Technology in environmental infection prevention and control:
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
The Pros and Cons of Automated Room Decontamination
Decontamination of medical devices
Counting the cost and value of hospital cleaning and disinfection
Carbapenem-resistant Gram-negative bacteria
The Use of Molecular Epidemiology and
From hospital microbiome to new answers for environmental cleaning
Cost utility of alternative Carbapenemase
Fast and expensive or cheap and slow
The role of environmental surfaces in disease transmission
Measuring and improving compliance with risk-factor based CPE admission screening Siddharth Mookerjee,1 Kate Martin, 1 Itziar Atucha-Zambrano, 1 Rebecca.
AMR: a clinical perspective
CPE: coming to a hospital near you!
C.Difficile update – what you need to know in Primary Care
Detecting and managing CPE outbreaks: seek and you shall find
Hospital cleaning and disinfection: we can do better!
Training XX Hospital.
Removal of sinks from ICU Patient rooms
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019.
Prevention of Clostridium difficile Associated Disease (CDAD) with an Active Surveillance and Contact Isolation Program for Asymptomatic C. difficile.
March 9th, 2019 Brooke K. Decker, MD, CIC
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
An introduction to infectious diseases epidemiology
Wiping out infection Dr Mark Garvey Consultant Clinical Scientist
Presentation transcript:

Healthcare-associated C. difficile infections: acquisition of C Healthcare-associated C. difficile infections: acquisition of C. difficile not antibiotic use is the most important factor Jon Otter, PhD FRCPath Honorary Senior Lecturer in HCAI and AMR, Imperial College London j.otter@imperial.ac.uk @jonotter Blog: www.ReflectionsIPC.com Slides: www.jonotter.net

Trends in HCAI in England

Gastric acid inhibitors Drivers of C. difficile Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Gastric acid inhibitors Drivers of C. difficile Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Rates of colonisation with C. difficile 0.5%1 Up to 50% 2 5% 3 FMT 4 Colonised patients 5.9 x higher risk of subsequent CDI (RR 5.86; 95% CI 4.2-8.2).3 Manzoor et al. J Hosp Infect 2017;97:153-5. Hung et al. J Microbiol Immunol Infect 2015;48:241-8. Zacharioudakis et al. Am J Gastroenterol 2015;110:381-90. Allegretti et al. Clin Microbiol Infect. 2017;24:780.e1-780.e3.

Patient exposures promoting gut dysbiosis Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Antibiotics aren’t the only cause of gut dysbiosis Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors Systematic review and meta-analysis of risk factors for CA-CDI. Antibiotic exposure was associated with a higher risk of CA-CDI in the US (OR, 9.16; 95% CI, 5.47–15.34) compared with Europe (4.54, 2.68–7.70), whereas proton-pump inhibitor exposure was associated with a higher risk in Europe (OR, 2.56; 95% CI, 1.40–4.71) than in the US (1.12, 0.64–1.95). Furuya-Kanamori et al. Infect Control Hosp Epidemiol 2015;36:132-41.

The English C. difficile miracle Mandatory reporting, 2004 ‘Cleanyourhands’, 2004 ‘A matron's charter: an action plan for cleaner hospitals’,2004 ‘Towards cleaner hospitals and lower rates of infection’, 2004 Health Act, 2006 ‘Going Further Faster,’ 2006 Targets, 2007 Saving Lives,2007 Deep clean, 2007 Revised guidelines, 2009 1,2,3 5,6 7,8,9 10

Spurious correlations http://www.tylervigen.com/spurious-correlations

Is the English C. difficile miracle explained by fluoroquinolones? Reductions in CDI in the Oxfordshire region correlated with reduced fluoroquinolone use. Fluoroquinolone-resistant strains disproportionately affected by the reduction in fluoroquinolone use. Dingle et al. Lancet Infect Dis 2017;17:411-21.

Is the English C. difficile miracle explained by fluoroquinolones? Secondary transmission of fluoroquinolone-resistant isolates reduced, both for isolates with and without a link to hospitals. However, secondary transmission of fluoroquinolone-susceptible isolates did not change significantly. This supports the idea that reducing the selective pressure of fluoroquinolone use was more important than hospital infection control interventions. Dingle et al. Lancet Infect Dis 2017;17:411-21.

Why antibiotic susceptible bacteria are resistant to hospital-based IPC intervention Mathematical model to investigate transmission in hospitals and their surrounding catchment area. Included a competitive advantage for resistant bacteria in hospitals and sensitive bacteria in the community. Modelling the impact of improving hand hygiene by 10%. Antibiotic-resistant bacteria were disproportionately affected in hospitals! van Kleef et al. BMC Infect Dis 2013;13:294.

Why antibiotic susceptible bacteria are resistant to hospital-based IPC intervention van Kleef et al. BMC Infect Dis 2013;13:294.

The acquisition of C. difficile Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Isn’t it proven that patient to patient transmission is a rare cause of healthcare-associated CDI? Epidemiological relationships between 333 genetically related cases. ‘Ward contact’ = shared time on the same ward; ‘Hospital contact’ = shared time in the same hospital, without direct ward contact; ‘Ward contamination’ = admitted to the same ward within 28 days of the discharge of a symptomatic patient; ‘Same GP’ = no hospital contact, but shared the same GP; ‘Same postcode’ = no hospital contact, but shared the same postal code). Eyre et al. New Engl J Med 2013;369:1195-1205.

Sensitivity of lab test method used can be very low (~50%)1 Only half the story… Sensitivity of lab test method used can be very low (~50%)1 C. difficile contamination of hospital and air is common in hospitals.2,3 Asymptomatic carriers were not included. Of 56 cases of CDI, 17 were associated with symptomatic patients, and 16 with asymptomatic carriers.4 Humphreys et al. J Clin Microbiol 2013;51:869-873. Otter et al. Infect Control Hosp Epidemiol. 2011;32:687-99. Best et al. Clin Infect Dis 2010;50:1450-7. Curry et al. Clin Infect Dis. 2013;57:1094-102.

The role of the environment in C. difficle transmission Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Your hospital room can make you sick! Mitchell et al. J Hosp Infect 2015;91:211-217.

0.4 2.4 Wiping away infection cases / 1000 patient days Impact of changing from QAC to chlorine wipes for daily disinfection of all rooms. Cleaning thoroughness was 97-98% throughout the study using ATP benchmarking (<250 RLUs). 0.4 cases / 1000 patient days 2.4 cases / 1000 patient days Orenstein et al. Infect Control Hosp Epidemiol 2011;34:521-523.

HPV: clinical impact 2 years before HPV, 2 years during HPV. Breakpoint model indicated significant reduction in rate of CDI when HPV implemented (1.0 to 0.4 per 1000 patient days, 60% reduction). McCord et al. J Hosp Infect 2016;94:185-7.

40% Scaling the reduction Study ARD system Design Outcome Confounders McCord 2016 HPV 4 year before-after CDI rate fell from 1.0 to 0.4 cases per 1,000 pt days; 60% reduction, p<0.001. No data on IPC compliance / abx use. Horn 2015 3 year before-after CDI rate fell from 1.4 to 0.9 cases per 1,000 patient days; 36% reduction. P<0.001. Concurrent increase in hand hygiene compliance. Manian 2013 2 year before-after CDI rate fell from 0.9 to 0.5 cases per 1,000 pt days; 39% reduction (IRR=0.63, CI=0.50-0.79, p<0.001). Chlorine disinfection enhanced concurrently. Boyce 2008 CDI rate fell from 1.9 to 0.9 cases per 1,000 pt days on high-risk wards; 53% reduction, p=0.047). Outbreak? No significant reduction hospital wide; changes in abx usage. Anderson 2018 UVC 2 year cluster RCT CDI rate fell from 1.0 to 0.9 cases per 1,000 patient days (RR 0.89, 95% CI, 0.80–0.99; p=0.031); 11% reduction. This RCT was controlled carefully for key confounders including IPC practice but not abx use. Pegues 2016 2 yr before -after CDI rate fell from 3.0 to 2.3 cases per 1,000 pt days; 27% reduction. Monitored potential confounders Napolitano 2015 3 yr before -after CDI rate fell from 1.2 to 0.7 cases per 1,000 pt days; 42% reduction. Vianna 2016 PX-UV 4 yr before - after CDI rate fell from 0.7 to 0.4 cases per 1,000 pt days; 40% reduction. Levin 2013 CDI rate fell from 0.9 to 0.4 cases per 1,000 pt days; 53% reduction. Abx changes. 40%

The role of hand hygiene in C. difficle transmission Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastric acid inhibitors

Evidence that improved hand hygiene reduces CDI Increased procurement of soap was independently associated with reduced CDI throughout the study (each 10 mL increase per patient bed day associated with a 7% reduction in CDI, adjusted incidence rate ratio 0.993, 95% CI 0.990 to 0.996; P<0.0001). Conversely, increased procurement of alcohol hand rub was independently associated with increased CDI (adjusted incidence rate ratio 1.010, 95% CI 1.006 to 1.013; P<0.0001). Stone et al. BMJ 2012;344:e3005..

Time to tackle C. difficile asymptomatic colonisation Lab testing Targets Patient sampling Acquisition Sources Humans Animals Food Soil Transmission routes Hands Environment Patient exposures Antibiotics Immuno-therapy Chemo-therapy Gut surgery Gastic acid inhibitors

Time to start screening and isolation for C. difficile? Introducing PCR screening for C. difficile (tcdB) resulting in a significant reduction in CDI; 63 of 101 (62.4%) expected cases were prevented. Longtin et al. JAMA Intern Med 2016;176:796-804.

The sufficient-component cause model Necessary Sufficient Antibiotic exposure ✘ C. difficile acquisition ✓ ?

You can suffer C. difficile infection without exposure to antibiotics, but you can’t suffer C. difficile infection without exposure to C. difficile!